메뉴 건너뛰기




Volumn 1024, Issue , 2004, Pages 54-71

Physiological and pathological consequences of the interactions of the p53 tumor suppressor with the glucocorticoid, androgen, and estrogen receptors

Author keywords

Addison's disease; Anemia; Cancer progression; Cushing's syndrome; Hematological malignancies; Skin carcinogenesis; Stress erythropoiesis

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; CCAAT ENHANCER BINDING PROTEIN; DEXAMETHASONE; ESTROGEN RECEPTOR; GENE PRODUCT; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOSE; ONCOPROTEIN; PROTEIN BAX; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; UBIQUITIN PROTEIN LIGASE;

EID: 3042795223     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1321.005     Document Type: Conference Paper
Times cited : (72)

References (137)
  • 1
    • 0033574663 scopus 로고    scopus 로고
    • NUCLEAR, RECEPTOR, AND COMMTITEE. 1999. Cell 97: 161-163.
    • (1999) Cell , vol.97 , pp. 161-163
  • 41
    • 0002023121 scopus 로고    scopus 로고
    • S. Wu-Pong & Y. Rojanasakul, Eds.: Humana Press, Inc. Totowa, NJ
    • VALERIE, K. 1999. In Biopharmaceutical Drug Design and Development. S. Wu-Pong & Y. Rojanasakul, Eds.: 69-105. Humana Press, Inc. Totowa, NJ.
    • (1999) Biopharmaceutical Drug Design and Development , pp. 69-105
    • Valerie, K.1
  • 109


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.